Per Kogner

Per Kogner is a Professor/Senior Physician at Karolinska Institutet, affiliated with the Department of Women's and Children's Health and the Pediatric Oncology and Pediatric Surgery division. He leads the Per Kogner and John Inge Johnsen research group, focusing on neuroblastoma and pediatric oncology. His research integrates genetic, epigenetic, and immunological approaches to understand tumor progression and develop novel therapies.

Key areas of research include genetic drivers of neuroblastoma (e.g., chromosome 17 gains, MYCN amplification), therapeutic targets (e.g., METTL3, WIP1), and immune profiling for precision medicine. He has authored over 300 publications, including high-impact studies in Cell, Nature, and Cancer Cell.

Collaborations span clinical trials, translational research, and international networks like the International Society of Paediatric Oncology (SIOP). His work has informed treatment guidelines and advanced therapies for high-risk neuroblastoma patients.